We are seeing increased interest among device companies to use the Special Access Trial process in Canada. One such 15 patient trial in Quebec engendered discussion about whether locally admitted insurance was needed. The consensus seemed to indicate that Gemini paper was acceptable, through Berkley Life Sciences. Premium is approximately $5,000 for $1M coverage limit, $7,000 for $2M.
Leave a Reply